View Item 

Show simple item record

A survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross-disease analyses
dc.contributor.authorGarcia-Etxebarria, Koldo
dc.contributor.authorCarbone, Florencia
dc.contributor.authorTeder-Laving, Maris
dc.contributor.authorPandit, Anita
dc.contributor.authorHolvoet, Lieselot
dc.contributor.authorThijs, Vincent
dc.contributor.authorLemmens, Robin
dc.contributor.authorBujanda, Luis
dc.contributor.authorFranke, Andre
dc.contributor.authorZöllner, Sebastian
dc.contributor.authorBoehnke, Michael
dc.contributor.authorZawistowski, Matthew
dc.contributor.authorEsko, Tonu
dc.contributor.authorJan, Tack
dc.contributor.authorD’Amato, Mauro
dc.date.accessioned2022-06-01T20:29:32Z
dc.date.available2023-07-01 16:29:30en
dc.date.available2022-06-01T20:29:32Z
dc.date.issued2022-06
dc.identifier.citationGarcia-Etxebarria, Koldo ; Carbone, Florencia; Teder-Laving, Maris ; Pandit, Anita; Holvoet, Lieselot; Thijs, Vincent; Lemmens, Robin; Bujanda, Luis; Franke, Andre; Zöllner, Sebastian ; Boehnke, Michael; Zawistowski, Matthew; Esko, Tonu; Jan, Tack; D’Amato, Mauro (2022). "A survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross- disease analyses." Neurogastroenterology & Motility (6): n/a-n/a.
dc.identifier.issn1350-1925
dc.identifier.issn1365-2982
dc.identifier.urihttps://hdl.handle.net/2027.42/172823
dc.description.abstractBackgroundFunctional dyspepsia (FD) is a common gastrointestinal condition of poorly understood pathophysiology. While symptoms’ overlap with other conditions may indicate common pathogenetic mechanisms, genetic predisposition is suspected but has not been adequately investigated.MethodsUsing healthcare, questionnaire, and genetic data from three large population-based biobanks (UK Biobank, EGCUT, and MGI), we surveyed FD comorbidities, heritability, and genetic correlations across a wide spectrum of conditions and traits in 10,078 cases and 351,282 non-FD controls of European ancestry.Key ResultsIn UK Biobank, 281 diagnoses were detected at increased prevalence in FD, based on healthcare records. Among these, gastrointestinal conditions (OR = 4.0, p < 1.0 × 10−300), anxiety disorders (OR = 2.3, p < 1.4 × 10−27), ischemic heart disease (OR = 2.2, p < 2.3 × 10−76), and infectious and parasitic diseases (OR = 2.1, p = 1.5 × 10−73) showed strongest association with FD. Similar results were obtained in an analysis of self-reported conditions and use of medications from questionnaire data. Based on a genome-wide association meta-analysis of genotypes across all cohorts, FD heritability was estimated close to 5% (hSNP2 = 0.047, p = 0.014). Genetic correlations indicate FD predisposition is shared with several other diseases and traits (rg > 0.344), mostly overlapping with those also enriched in FD patients. Suggestive (p < 5.0 × 10−6) association with FD risk was detected for 13 loci, with 2 showing nominal replication (p < 0.05) in an independent cohort of 192 FD patients.Conclusions & InferencesFD has a weak heritable component that shows commonalities with multiple conditions across a wide spectrum of pathophysiological domains. This new knowledge contributes to a better understanding of FD etiology and may have implications for improving its treatment.FD has a weak heritable component that shows commonalities with multiple conditions across a wide spectrum of pathophysiological domains, including other GI conditions and mood/anxiety disorders.
dc.publisherWiley Periodicals, Inc.
dc.publisherIntechOpen Limited
dc.subject.othercomorbidities
dc.subject.othergenetics
dc.subject.otherfunctional dyspepsia
dc.subject.otherbiobank studies
dc.subject.othergenome-wide association study
dc.titleA survey of functional dyspepsia in 361,360 individuals: Phenotypic and genetic cross-disease analyses
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/172823/1/nmo14236-sup-0001-Supinfo.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/172823/2/nmo14236_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/172823/3/nmo14236.pdf
dc.identifier.doi10.1111/nmo.14236
dc.identifier.sourceNeurogastroenterology & Motility
dc.identifier.citedreferenceAziz I, Palsson OS, Törnblom H, Sperber AD, Whitehead WE, Simrén M. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018; 3 ( 4 ): 252 - 262.
dc.identifier.citedreferenceLee KJ, Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil. 2010; 16 ( 3 ): 251 - 257.
dc.identifier.citedreferenceGathaiya N, Locke GR, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009; 21 ( 9 ): 922 -e69.
dc.identifier.citedreferenceTriantafyllou K, Kourikou A, Gazouli M, Karamanolis GP, Dimitriadis GD. Functional dyspepsia susceptibility is related to CD14, GNB3, MIF, and TRPV1 gene polymorphisms in the Greek population. Neurogastroenterol Motil. 2017; 29 ( 1 ): 1 - 8.
dc.identifier.citedreferenceBycroft C, Freeman C, Petkova D, et al. The UK biobank resource with deep phenotyping and genomic data. Nature. 2018; 562 ( 7726 ): 203 - 209.
dc.identifier.citedreferenceLeitsalu L, Haller T, Esko T, et al. Cohort profile: Estonian biobank of the Estonian genome center, university of Tartu. Int J Epidemiol. 2015; 44 ( 4 ): 1137 - 1147.
dc.identifier.citedreferenceFritsche LG, Gruber SB, Wu Z, et al. Association of polygenic risk scores for multiple cancers in a phenome-wide study: results from the michigan genomics initiative. Am J Hum Genet. 2018; 102 ( 6 ): 1048 - 1061.
dc.identifier.citedreferenceMeschia JF, Arnett DK, Ay H, et al. Stroke genetics network (SiGN) study design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke. 2013; 44 ( 10 ): 2694 - 2702.
dc.identifier.citedreferenceZhou W, Nielsen JB, Fritsche LG, et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet. 2018; 50 ( 9 ): 1335 - 1341.
dc.identifier.citedreferenceWinkler TW, Day FR, Croteau-Chonka DC, et al. Quality control and conduct of genome-wide association meta-analyses. Nat Protoc. 2014; 9 ( 5 ): 1192 - 1212.
dc.identifier.citedreferenceWiller CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010; 26 ( 17 ): 2190 - 2191.
dc.identifier.citedreferenceWatanabe K, Taskesen E, Van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017; 8 ( 1 ): 1826.
dc.identifier.citedreferenceStaley JR, Blackshaw J, Kamat MA, et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics. 2016; 32 ( 20 ): 3207 - 3209.
dc.identifier.citedreferenceKamat MA, Blackshaw JA, Young R, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019; 35 ( 22 ): 4851 - 4853.
dc.identifier.citedreferenceBulik-Sullivan B, Finucane HK, Anttila V, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015; 47 ( 11 ): 1236 - 1241.
dc.identifier.citedreferenceChang CC, Chow CC, Tellier LCAM, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015; 4: 7.
dc.identifier.citedreferenceBrook RA, Kleinman NL, Choung RS, Smeeding JE, Talley NJ. Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population. Dig Dis Sci. 2012; 57 ( 1 ): 109 - 118.
dc.identifier.citedreferenceJarbøl DE, Rasmussen S, Balasubramaniam K, Elnegaard S, Haastrup PF. Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome – a population based study. BMC Gastroenterol. 2017; 17 ( 1 ): 1 - 9.
dc.identifier.citedreferenceDe Bortoli N, Tolone S, Frazzoni M, et al. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann Gastroenterol. 2018; 31 ( 6 ): 639 - 648.
dc.identifier.citedreferencevon Wulffen M, Talley NJ, Hammer J, et al. Overlap of irritable bowel syndrome and functional dyspepsia in the clinical setting: prevalence and risk factors. Dig Dis Sci. 2019; 64 ( 2 ): 480 - 486.
dc.identifier.citedreferenceGeeraerts A, Van Houtte B, Clevers E, et al. Gastroesophageal reflux disease—functional dyspepsia overlap: do birds of a feather flock together? Am J Gastroenterol. 2020; 115 ( 8 ): 1167 - 1182.
dc.identifier.citedreferenceBharucha AE, Chakraborty S, Sletten CD. Common functional gastroenterological disorders associated with abdominal pain. Mayo Clin Proc. 2016; 91 ( 8 ): 1118 - 1132.
dc.identifier.citedreferenceCarbone F, Vanuytsel T, Tack J. Analysis of postprandial symptom patterns in subgroups of patients with Rome III or Rome IV functional dyspepsia. Clin Gastroenterol Hepatol. 2020; 18 ( 4 ): 838 - 846.e3.
dc.identifier.citedreferenceLatenstein CSS, de Jong JJ, Eppink JJ, et al. Prevalence of dyspepsia in patients with cholecystolithiasis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2019; 31 ( 8 ): 928 - 934.
dc.identifier.citedreferenceAro P, Talley NJ, Ronkainen J, et al. Anxiety is associated with uninvestigated and functional dyspepsia (Rome III Criteria) in a Swedish population-based study. Gastroenterology. 2009; 137 ( 1 ): 94 - 100.
dc.identifier.citedreferenceClauwaert N, Jones MP, Holvoet L, et al. Associations between gastric sensorimotor function, depression, somatization, and symptom-based subgroups in functional gastroduodenal disorders: are all symptoms equal? Neurogastroenterol Motil. 2012; 24 ( 12 ): 1088 -e565.
dc.identifier.citedreferencePinto-Sanchez MI, Ford AC, Avila CA, et al. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol. 2015; 110 ( 7 ): 1038 - 1048.
dc.identifier.citedreferenceAndersen BN, Johansen PB, Abrahamsen B. Proton pump inhibitors and osteoporosis. Curr Opin Rheumatol. 2016; 28 ( 4 ): 420 - 425.
dc.identifier.citedreferenceKoloski N, Jones M, Walker MM, et al. Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Aliment Pharmacol Ther. 2019; 49 ( 5 ): 546 - 555.
dc.identifier.citedreferenceFord AC, Talley NJ, Walker MM, Jones MP. Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case–control study of 23 471 primary care patients. Aliment Pharmacol Ther. 2014; 40 ( 7 ): 827 - 834.
dc.identifier.citedreferenceSong X-H, Xu X-X, Ding L-W, Cao L, Sadel A, Wen H. A preliminary study of neck-stomach syndrome. World J Gastroenterol. 2007; 13 ( 18 ): 2575 - 2580.
dc.identifier.citedreferenceColeman CI, Limone BL, Schein JR, et al. Upper gastrointestinal symptoms and cardiovascular disease. In: Curley M, Shaffer E, eds. Dyspepsia – Advances in Understanding and Management. IntechOpen Limited; 2013: 135 - 168.
dc.identifier.citedreferenceWouters MM, Lambrechts D, Knapp M, et al. Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome. Gut. 2014; 63: 1103 - 1111.
dc.identifier.citedreferenceBorn G, Breuer D, Wang S, et al. Modulation of synaptic function through the α-neurexin–specific ligand neurexophilin-1. Proc Natl Acad Sci. 2014; 111 ( 13 ): E1274 - E1283.
dc.identifier.citedreferenceBeglopoulos V, Montag-Sallaz M, Rohlmann A, et al. Neurexophilin 3 is highly localized in cortical and cerebellar regions and is functionally important for sensorimotor gating and motor coordination. Mol Cell Biol. 2005; 25 ( 16 ): 7278 - 7288.
dc.identifier.citedreferenceSalemi LM, Maitland MER, Yefet ER, Schild-Poulter C. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex. BMC Cancer. 2017; 17 ( 1 ): 1 - 16.
dc.identifier.citedreferenceStanghellini V, Chan FKL, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016; 150 ( 6 ): 1380 - 1392.
dc.identifier.citedreferenceSperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology. 2021; 160 ( 1 ): 99 - 114.
dc.identifier.citedreferenceDrossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology. 2016; 150 ( 6 ): 1262 - 1279.e2.
dc.identifier.citedreferencepiessevaux H, de winter B, louis E, et al. Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil. 2009; 21 ( 4 ): 378 - 388.
dc.identifier.citedreferenceCamilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US upper gastrointestinal study. Clin Gastroenterol Hepatol. 2005; 3 ( 6 ): 543 - 552.
dc.identifier.citedreferenceBrook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010; 8 ( 6 ): 498 - 503.
dc.identifier.citedreferenceFord AC, Forman D, Bailey AG, Axon ATR, Moayyedi P. Effect of dyspepsia on survival: a longitudinal 10-year follow-up study. Am J Gastroenterol. 2012; 107 ( 6 ): 912 - 921.
dc.identifier.citedreferenceCamilleri M, Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013; 10 ( 3 ): 187 - 194.
dc.identifier.citedreferenceMasuy I, Van Oudenhove L, Tack J. Review article: treatment options for functional dyspepsia. Aliment Pharmacol Ther. 2019; 49 ( 9 ): 1134 - 1172.
dc.identifier.citedreferenceTack J. Prokinetics and fundic relaxants in upper functional GI disorders. Curr Opin Pharmacol. 2008; 8 ( 6 ): 690 - 696.
dc.identifier.citedreferenceBurns G, Carroll G, Mathe A, et al. Evidence for local and systemic immune activation in functional dyspepsia and the irritable bowel syndrome: a systematic review. Am J Gastroenterol. 2019; 114 ( 3 ): 429 - 436.
dc.identifier.citedreferenceCirillo C, Bessissow T, Desmet AS, Vanheel H, Tack J, Vanden BP. Evidence for neuronal and structural changes in submucous ganglia of patients with functional dyspepsia. Am J Gastroenterol. 2015; 110 ( 8 ): 1205 - 1215.
dc.identifier.citedreferenceCarbone F, Tack J. Gastroduodenal mechanisms underlying functional gastric disorders. Dig Dis. 2014; 32 ( 3 ): 222 - 229.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
nmo14236-sup-0001-Supinfo.pdf
Size:
496.5KB
Format:
PDF
View/Open
Name:
nmo14236_am.pdf
Size:
438.1KB
Format:
PDF
View/Open
Name:
nmo14236.pdf
Size:
1.059MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.